Literature DB >> 2654324

Influence of the thymus on the capacity of female mice to reject male skin grafts.

E S De Pirro1, E H Goldberg.   

Abstract

The ability of female mice to reject H-Y-incompatible, but otherwise histocompatible, male skin grafts differs greatly from strain to strain, as is illustrated particularly by the C57BL strain (B6 and other sublines), termed "H-Y rejector," because females invariably and promptly reject C57BL male skin, in comparison with the C3H strain, termed "H-Y nonrejector," because females characteristically accept male C3H skin. To assess the extent to which the thymus governs this rejector vs. nonrejector status, two studies were made. In the first, lethally irradiated B6 (C57BL) and C3H females were restored with (B6 X C3H)F1 female cells, providing a graft-vs.-host-free milieu for differentiation of the same immunopoietic cell population in B6 vs. C3H hosts. With respect to (B6 X C3H)F1 male skin grafts, B6 hosts responded as rejectors and C3H hosts as nonrejectors, signifying that rejector vs. nonrejector status was determined by the host during immunopoiesis. That the main organ responsible for rejector vs. nonrejector determination is the thymus was shown in a second study. Previously thymectomized (B6 X C3H)F1 females received a histocompatible graft of thymus from either B6 or C3H neonatal females and were restored with donor-marked (B6-Ly-5a X C3H)F1 female cells after lethal irradiation. With respect to (B6 X C3H)F1 male skin grafts, the recipients of B6 thymus grafts responded generally as rejectors and the recipients of C3H thymus grafts responded uniformly as nonrejectors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2654324      PMCID: PMC2189322          DOI: 10.1084/jem.169.5.1829

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  Rejection of male skin grafts by splenectomized female mice.

Authors:  T A Coons; E H Goldberg
Journal:  Science       Date:  1978-04-21       Impact factor: 47.728

2.  Detection of H-Y (male) antigen on mouse lymph node cells by the cell to cell cytotoxicity test.

Authors:  E H Goldberg; F W Shen; S Tokuda
Journal:  Transplantation       Date:  1973-03       Impact factor: 4.939

3.  Allelic forms of a gene controlling the female immune response to the male antigen in mice.

Authors:  D W Bailey
Journal:  Transplantation       Date:  1971-04       Impact factor: 4.939

4.  Genetic control of the immune response in mice. 3. An association between H-2 type and reaction to H-Y.

Authors:  D L Gasser; W K Silvers
Journal:  J Immunol       Date:  1971-03       Impact factor: 5.422

5.  Major histocompatibility complex-linked immune-responsiveness is acquired by lymphocytes of low-responder mice differentiating in thymus of high-responder mice.

Authors:  H von Boehmer; W Haas; N K Jerne
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

6.  Effect of thymectomy on the cell-mediated cytotoxicity response to male skin grafts in C3H/HeN female mice.

Authors:  E H Goldberg; S E Arritt
Journal:  Transplantation       Date:  1982-02       Impact factor: 4.939

7.  Effect of the TP5 analogue of thymopoietin on the rejection of male skin by aged and thymectomized female mice.

Authors:  E H Goldberg; G Goldstein; E A Boyse; M P Scheid
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

8.  Regulatory influence of thymopentin on splenic T cell sets of thymectomized and aged mice.

Authors:  E W Newcomb; E H Goldberg; M de Sousa; G Goldstein; E A Boyse; M P Scheid
Journal:  Transplantation       Date:  1985-11       Impact factor: 4.939

9.  In vitro cell-mediated immune responses to the male specific(H-Y) antigen in mice.

Authors:  R D Gordon; E Simpson; L E Samelson
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

10.  Cytotoxic T-cell responses to H-Y: correlation with the rejection of syngeneic male skin grafts.

Authors:  M Hurme; P R Chandler; C M Hetherington; E Simpson
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.